BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26111667)

  • 1. Plasma Uric Acid as a Prognostic Marker in Patients With Hypertrophic Cardiomyopathy.
    Zhu L; Wang J; Wang Y; Jia L; Sun K; Wang H; Zou Y; Tian T; Liu Y; Zou J; Hui R; Yuan Z; Song L
    Can J Cardiol; 2015 Oct; 31(10):1252-8. PubMed ID: 26111667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Significance of Plasma High-Sensitivity C-Reactive Protein in Patients With Hypertrophic Cardiomyopathy.
    Zhu L; Zou Y; Wang Y; Luo X; Sun K; Wang H; Jia L; Liu Y; Zou J; Yuan Z; Hui R; Kang L; Song L; Wang J
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28154166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of high-sensitivity cardiac troponin T in hypertrophic cardiomyopathy.
    Kubo T; Kitaoka H; Yamanaka S; Hirota T; Baba Y; Hayashi K; Iiyama T; Kumagai N; Tanioka K; Yamasaki N; Matsumura Y; Furuno T; Sugiura T; Doi YL
    J Am Coll Cardiol; 2013 Oct; 62(14):1252-1259. PubMed ID: 23623916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy.
    Chan RH; Maron BJ; Olivotto I; Pencina MJ; Assenza GE; Haas T; Lesser JR; Gruner C; Crean AM; Rakowski H; Udelson JE; Rowin E; Lombardi M; Cecchi F; Tomberli B; Spirito P; Formisano F; Biagini E; Rapezzi C; De Cecco CN; Autore C; Cook EF; Hong SN; Gibson CM; Manning WJ; Appelbaum E; Maron MS
    Circulation; 2014 Aug; 130(6):484-95. PubMed ID: 25092278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Significance of Fragmented QRS in Patients with Hypertrophic Cardiomyopathy.
    Lu X; Wang W; Zhu L; Wang Y; Sun K; Zou Y; Tian T; Hui R; Wang J; Kang L; Song L
    Cardiology; 2017; 138(1):26-33. PubMed ID: 28554182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical profile and prognostic significance of atrial fibrillation in hypertrophic cardiomyopathy.
    Tian T; Wang Y; Sun K; Wang J; Zou Y; Zhang W; Bao J; Zhu L; Shen H; Hui R; Zhou X; Song L
    Cardiology; 2013; 126(4):258-64. PubMed ID: 24157592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uric Acid as a Marker of Mortality and Morbidity in Fabry Disease.
    Rob D; Marek J; Dostálová G; Goláň L; Linhart A
    PLoS One; 2016; 11(11):e0166290. PubMed ID: 27835692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the association between serum uric acid level andthe predicted risk score of sudden cardiac death in five years in patients with hypertrophic cardiomyopathy.
    Özyılmaz S; Satılmışoğlu MH; Gül M; Uyarel H; Serdar OA
    Turk Kardiyol Dern Ars; 2018 Mar; 46(2):111-120. PubMed ID: 29512627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiopulmonary Exercise Testing and Prognosis in Hypertrophic Cardiomyopathy.
    Coats CJ; Rantell K; Bartnik A; Patel A; Mist B; McKenna WJ; Elliott PM
    Circ Heart Fail; 2015 Nov; 8(6):1022-31. PubMed ID: 26374874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in uric acid levels and allopurinol use in chronic heart failure: association with improved survival.
    Gotsman I; Keren A; Lotan C; Zwas DR
    J Card Fail; 2012 Sep; 18(9):694-701. PubMed ID: 22939038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragmented QRS as a candidate marker for high-risk assessment in hypertrophic cardiomyopathy.
    Kang KW; Janardhan AH; Jung KT; Lee HS; Lee MH; Hwang HJ
    Heart Rhythm; 2014 Aug; 11(8):1433-40. PubMed ID: 24813377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy.
    O'Hanlon R; Grasso A; Roughton M; Moon JC; Clark S; Wage R; Webb J; Kulkarni M; Dawson D; Sulaibeekh L; Chandrasekaran B; Bucciarelli-Ducci C; Pasquale F; Cowie MR; McKenna WJ; Sheppard MN; Elliott PM; Pennell DJ; Prasad SK
    J Am Coll Cardiol; 2010 Sep; 56(11):867-74. PubMed ID: 20688032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of Free Triiodothyronine Level in Patients With Hypertrophic Obstructive Cardiomyopathy.
    Zhang K; Meng X; Wang W; Zheng J; An S; Wang S; Qi Y; Gao C; Tang YD
    J Clin Endocrinol Metab; 2018 Mar; 103(3):1198-1205. PubMed ID: 29304228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Characteristics and Prognosis of End-stage Hypertrophic Cardiomyopathy.
    Xiao Y; Yang KQ; Yang YK; Liu YX; Tian T; Song L; Jiang XJ; Zhou XL
    Chin Med J (Engl); 2015 Jun; 128(11):1483-9. PubMed ID: 26021505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between serum uric acid and all-cause and cardiovascular mortality in patients treated with peritoneal dialysis.
    Xia X; He F; Wu X; Peng F; Huang F; Yu X
    Am J Kidney Dis; 2014 Aug; 64(2):257-64. PubMed ID: 24176223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term prognostic value of lowering in free triiodothyronine in patients with hypertrophic cardiomyopathy].
    Meng XB; Wang WY; Zhang K; Qi Y; An SM; Wang SY; Zheng JL; Yu QJ; Tang B; Wu R; Gao CY; Wang SY; Tang YD
    Zhonghua Nei Ke Za Zhi; 2018 Apr; 57(4):258-263. PubMed ID: 29614583
    [No Abstract]   [Full Text] [Related]  

  • 17. Obesity and its association to phenotype and clinical course in hypertrophic cardiomyopathy.
    Olivotto I; Maron BJ; Tomberli B; Appelbaum E; Salton C; Haas TS; Gibson CM; Nistri S; Servettini E; Chan RH; Udelson JE; Lesser JR; Cecchi F; Manning WJ; Maron MS
    J Am Coll Cardiol; 2013 Jul; 62(5):449-57. PubMed ID: 23643593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma level of big endothelin-1 predicts the prognosis in patients with hypertrophic cardiomyopathy.
    Wang Y; Tang Y; Zou Y; Wang D; Zhu L; Tian T; Wang J; Bao J; Hui R; Kang L; Song L; Wang J
    Int J Cardiol; 2017 Sep; 243():283-289. PubMed ID: 28587741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperuricemia predicts adverse outcomes in patients with heart failure.
    Hamaguchi S; Furumoto T; Tsuchihashi-Makaya M; Goto K; Goto D; Yokota T; Kinugawa S; Yokoshiki H; Takeshita A; Tsutsui H;
    Int J Cardiol; 2011 Sep; 151(2):143-7. PubMed ID: 20542341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperuricemia in acute heart failure. More than a simple spectator?
    Alimonda AL; Núñez J; Núñez E; Husser O; Sanchis J; Bodí V; Miñana G; Robles R; Mainar L; Merlos P; Darmofal H; Llácer A
    Eur J Intern Med; 2009 Jan; 20(1):74-9. PubMed ID: 19237097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.